Stocks and Investing
Stocks and Investing
Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (TMCI) at Hold with Decreased Target to $7.5 on, Aug 7th, 2024
Richard Newitter of Truist Securities, Maintained "Treace Medical Concepts, Inc." (TMCI) at Hold with Decreased Target from $9 to $7.5 on, Aug 7th, 2024.
Richard has made no other calls on TMCI in the last 4 months.
There are 4 other peers that have a rating on TMCI. Out of the 4 peers that are also analyzing TMCI, all agree with Richard's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Drew Ranieri of "Morgan Stanley" Maintained at Hold with Increased Target to $8 on, Monday, July 15th, 2024
- Rick Wise of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, May 8th, 2024
- Robbie Marcus of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $8 on, Wednesday, May 8th, 2024
- Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, May 8th, 2024
Contributing Sources